Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Fimagen, Fimanta
Synonyms :
fimasartan
Class :
Angiotensin receptor blockers
Brand Name :
Fimagen, Fimanta
Synonyms :
fimasartan
Class :
Angiotensin receptor blockers
Dosage Forms & Strengths
Tablet
120 mg
not indicated
refer to adult dosing
they increase the efficacy of hypotension-associated agents
it reduces the efficacy of blood pressure-lowering agents
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may have an increased hypotensive effect when combined with hypotension-associated agents
may have an increased hypotensive effect when combined with hypotension-associated agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may increase the hypotensive effect of hypotensive agents
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
hypotensive agents increase the efficacy of duloxetine
it increases the efficacy of hypotensive agents
it increases the efficacy of hypotensive agents
hypotensive agents increase the blood pressure-lowering effect of nitroprusside
it increases the efficacy of hypotensive agents
may increase the hypotensive effect
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
eprosartan/hydrochlorothiazideÂ
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may have an increased hypotensive effect when combined with hypotensive agents
may have an increased hypotensive effect when combined with hypotensive agents
blood viscosity-reducing agents: they may increase the hypotensive effect when combined with hypotension-associated agents
blood viscosity-reducing agents: they may increase the hypotensive effect when combined with hypotension-associated agents
may enhance the QTc-prolonging effect of each other when combined
they increase the effect of hypotension of BP-lowering agents
they increase the effect of hypotension of BP-lowering agents
they increase the effect of hypotension of BP-lowering agents
they increase the effect of hypotension of BP-lowering agents
they increase the effect of hypotension of BP-lowering agents
it increases the effect of BP-lowering agents
it decreases the effect of hypotension of blood pressure lowering agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
it increases the effect of hypotension of blood pressure lowering agents
it increases the effect of hypotension of blood pressure lowering agents
it increases the effect of hypotension of blood lowering agents
blood pressure lowering agents increase the effect of hypotension of amifostine
it increases the effect of hypotension of BP-lowering agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
it increases the effect of hypotension of blood lowering agents
Actions and Spectrum:
fimasartan works by blocking the action of a hormone called angiotensin II. Angiotensin II is a powerful vasoconstrictor, meaning it causes blood vessels to narrow, which can lead to an increase in blood pressure. By blocking the effects of angiotensin II, fimasartan helps to relax and widen blood vessels, which in turn reduces blood pressure. This action makes it effective in treating hypertension.
Spectrum:
fimasartan’s primary use is in the management of high blood pressure (hypertension). However, it can also have additional benefits and uses:
Hypertension: fimasartan is indicated for the treatment of essential hypertension, which is high blood pressure without an identifiable cause. It can help lower blood pressure and reduce the risk of associated cardiovascular complications.
Cardiovascular Protection: fimasartan, like other ARBs, may provide cardiovascular protection by reducing the strain on the heart and blood vessels. It can be beneficial in individuals at risk of heart disease.
Kidney Protection: In some cases, fimasartan may be used to slow the progression of kidney disease in individuals with hypertension and diabetes. It can help protect the kidneys from further damage.
Heart Failure: fimasartan may also be considered as a treatment option for heart failure, particularly when other medications like ACE inhibitors are not well-tolerated by the patient.
Frequency not defined
Dizziness
Headache
Pregnancy category: N/A
Lactation: Excretion into human milk is unknown
Pregnancy Categories:     
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
Category B: There were lack of studies on pregnant women and no evidence of risk to the foetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient information leaflet
Generic Name: fimasartan
Why do we use fimasartan?
fimasartan is a medication primarily used to treat high blood pressure, also known as hypertension. It is an angiotensin II receptor blocker (ARB), and its primary purpose is to help lower blood pressure and manage hypertension.
The primary and most common use of fimasartan is to treat hypertension. Hypertension is a condition in which the force of blood against the walls of the arteries is consistently too high. High blood pressure can increase the risk of serious cardiovascular problems, including heart disease, stroke, and kidney disease. fimasartan works by relaxing and widening blood vessels, thereby lowering blood pressure.
fimasartan, like other ARBs, may provide cardiovascular protection by reducing the strain on the heart and blood vessels. It can be prescribed to individuals at risk of heart disease or stroke to help lower their blood pressure and reduce the risk of related complications.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
